Ashfield Engage acquires Nuvera 

Ashfield Engage acquires Nuvera 

Ashfield Engage, part of UDG Healthcare plc., has completed the acquisition of Nuvera LLC, a U.S.-based healthcare consulting firm specializing in patient support programs.

Ashfield describes Nuvera as experts in optimizing the design and build of seamless patient and HCP treatment experiences. “This expertise will enhance Ashfield Engage’s Patient Solutions capabilities and create an end-to-end strategic offering across their client’s product lifecycles,” company executives say.

With the acquisition, Ashfield Engage and Nuvera now offer integrated specialist support and services including late-phase clinical trial experience, implementation and post-commercialization satisfaction benchmarking and service optimization.

 “Combining the expertise of Ashfield and Nuvera creates a wealth of opportunities for our clients and patients,” says Nareda Mills, global president, Patient Solutions, Ashfield Engage. “By leveraging the strategic and operational insight of both organizations we will be able to bring our program implementation experience to the table earlier and influence the overall strategic direction of patient support, leading to better programs and results.”

Mills says, “Our combined expertise and capabilities will also allow greater visibility across the market landscape to better refine and refresh programs as new market challenges arise. This end-to-end understanding of the treatment experience will advance our patient programs, building best in class services that are meaningful for patients.”

Mills adds, “The Nuvera team is an exceptional asset to add to Ashfield Engage, they are pioneers in redefining the treatment experience and I am truly excited for what lies ahead.”

Founded in 2010, Nuvera has partnered with a multitude of larger pharmaceutical and emerging biotech commercial teams for over a decade, helping to develop industry leading patient support strategies and capabilities.